Re-imagine drug discovery
for genetic patients
with QRGenAI
Re-imagine
drug discovery
for
genetic patients
with QRGenAI
for genetic patients
with QRGenAI
drug discovery
for
genetic patients
with QRGenAI
For accelerating the identification of disease
cause and a proven track record
of new therapeutics
cause and a proven track record
of new therapeutics
From a rare genetic disease without treatment or unknown MOA
to drug discovery for millions of patients
QRGenetics implements QRGenAI techniques and exclusive datasets
swiftly identify novel targets and develop new drugs.
This strategy accelerates the creation of innovative therapies
revolutionizes medical treatment for individuals impacted by genetic disorders.
From rare genetic disease without treatment
to drug discovery for millions of patients
QRGenetics implements advanced QRGenAI techniques and exclusive datasets
swiftly identify novel targets and develop new drugs.
This strategy accelerates the creation of innovative therapies revolutionizes
medical treatment for individuals impacted by genetic disorders
Our Unique Discovery Process
Consolidate
Medical
data
data
Disease
data
data
Proprietary
database
database
Proprietary
Algorithms
Algorithms
Disease
Modeling
Modeling
Protein
Modeling
Modeling
Target
Identification
Identification
Drug
Discovery
Discovery
Validate
Rapid clinical validation through preclinical tests, & in-human trials
Expand
Proprietary
Algorithms
Algorithms
Gen AI-driven data processing identifies common diseases with functional dysfunctions similar to the mechanisms found in rare diseases.
Power
Develops an extensive library of validated new targets and discovers novel drugs ready for clinical trials
Our Discovery Edge
Expanding Indications
Broaden the impact of our treatments, benefiting millions of patients.
Broaden the impact of our treatments, benefiting millions of patients.
Rapid Target & Drug Identification
Accelerating from years
to months
Accelerating from years
to months
Advanced Technology
QRGen-AI combined with personal medical data, to identify disease targets and innovate drug discovery
QRGen-AI combined with personal medical data, to identify disease targets and innovate drug discovery
From Genetic Disease to Heart Failure
Genetic Indication
QRGenetics discover disease cause and treatment
Patients diagnosed with a life-threatening rare genetic disease caused by a point mutation that disrupts blood supply to multiple organs
Discover treatment
FDA-approved drug was matched and tested in a pre-clinical trial
Based on the results, an IND was submitted and a multi-centre clinical trial was initiated
Drug Indication
Expansion
Same drug was also found beneficial for
10,000,000
patients that suffers from genetic heart failure
Pipeline
Drug
program
program
Indication
type
type
Indication
name
name
Pre-clinical trial
Results
Clinical partner research
Clinical trial
QR-100
original
common
Neurodevelopmental disorder (NDPLH)
Autism Spectrum Disorder (ASD)
QR-755
original
Common
Common
Celiac Disease
Rheumatoid Arthritis (RA)
Inflammatory Bowel Disease (IBD)
QR-172
original
Common
Common
Common
Smooth Muscle Disease (MSMDS)
Heart failure
Abdominal and aortic Aneurysm
Myopathy
QR-9477
original
Common
to be disclosed
Obesity
QR-1355
original
Common
to be disclosed
ADPKD
